MOLECULIN BIOTECH, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • July 17th, 2020 • Moleculin Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 17th, 2020 Company Industry JurisdictionMoleculin Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with Oppenheimer & Co. Inc. (the “Agent”) as follows: